Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
5992.0000
77.50
(
1.31
%)
NSE
Aug 11, 2025
15:31 PM
29.82% Gain from 52W Low
Volume:
677.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
04 Feb 2023
5992.00
1.31%
Lower realization in API sales/ reduced operating leverage drag earnings
Neutral:
Divi's Laboratories Ltd.
by
Motilal Oswal
Target: 2620
Recommendation
Target
Motilal Oswal
Divi's Laboratories .. has an
average target
of 6447.40 from 5 brokers.
More from Divi's Laboratories Ltd.
Recommended
IPO action stays active with four new issues and six listings this week
|
11 Aug 2025, 06:17PM
Market closes higher, L&T wins an order worth over Rs 15,000 crore from Adani Power
Trendlyne Marketwatch |
11 Aug 2025, 03:56PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022